Nobuo Irokawa

519 total citations
35 papers, 425 citations indexed

About

Nobuo Irokawa is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, Nobuo Irokawa has authored 35 papers receiving a total of 425 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Pharmacology. Recurrent topics in Nobuo Irokawa's work include Hormonal Regulation and Hypertension (16 papers), Inflammatory mediators and NSAID effects (9 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). Nobuo Irokawa is often cited by papers focused on Hormonal Regulation and Hypertension (16 papers), Inflammatory mediators and NSAID effects (9 papers) and Eicosanoids and Hypertension Pharmacology (7 papers). Nobuo Irokawa collaborates with scholars based in Japan. Nobuo Irokawa's co-authors include KAORU YOSHINAGA, Minoru Yasujima, MASAHIDE SEINO, Keishi Abe, Tetsuo Saito, Satoru Chiba, Seiji Miyazaki, Yoshinori Sakurai, Yutaka Sakurai and Kentaro Ueno and has published in prestigious journals such as Circulation Research, American Heart Journal and Prostaglandins.

In The Last Decade

Nobuo Irokawa

30 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuo Irokawa Japan 11 156 118 116 99 85 35 425
T Haruyama Japan 12 83 0.5× 166 1.4× 78 0.7× 66 0.7× 92 1.1× 28 335
C Werning Germany 11 140 0.9× 92 0.8× 60 0.5× 27 0.3× 88 1.0× 56 400
P. Speckart United States 8 189 1.2× 55 0.5× 176 1.5× 26 0.3× 125 1.5× 9 589
Jorge A. Lopez-Ovejero United States 8 64 0.4× 175 1.5× 65 0.6× 26 0.3× 66 0.8× 11 390
Lawrence Levine United States 6 64 0.4× 209 1.8× 59 0.5× 32 0.3× 118 1.4× 8 415
Jiří Heller Czechia 12 113 0.7× 211 1.8× 52 0.4× 54 0.5× 111 1.3× 24 388
J. R. H. Brentjens Netherlands 5 40 0.3× 45 0.4× 183 1.6× 27 0.3× 45 0.5× 7 354
Markus Küng United States 10 64 0.4× 158 1.3× 41 0.4× 14 0.1× 69 0.8× 20 489
Jan Malý Czechia 15 209 1.3× 320 2.7× 70 0.6× 61 0.6× 64 0.8× 21 427
Ahmad A. Attallah United States 13 47 0.3× 56 0.5× 188 1.6× 8 0.1× 80 0.9× 26 386

Countries citing papers authored by Nobuo Irokawa

Since Specialization
Citations

This map shows the geographic impact of Nobuo Irokawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuo Irokawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuo Irokawa more than expected).

Fields of papers citing papers by Nobuo Irokawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuo Irokawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuo Irokawa. The network helps show where Nobuo Irokawa may publish in the future.

Co-authorship network of co-authors of Nobuo Irokawa

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuo Irokawa. A scholar is included among the top collaborators of Nobuo Irokawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuo Irokawa. Nobuo Irokawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abe, K., et al.. (1979). Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 120B. 487–501. 2 indexed citations
2.
Yasujima, Minoru, Keishi Abe, Satoru Chiba, et al.. (1979). Effects of indomethacin on plasma renin activity, plasma aldosterone concentration, urinary prostaglandin E excretion and blood pressure in patients with essential hypertension.. The Tohoku Journal of Experimental Medicine. 128(1). 31–37.
3.
Chiba, Satoru, Keishi Abe, Minoru Yasujima, et al.. (1979). Effect of triamterene on urinary excretion of immunoreactive prostaglandin E in essential hypertension.. The Tohoku Journal of Experimental Medicine. 129(3). 249–256. 1 indexed citations
4.
Irokawa, Nobuo, Keishi Abe, Minoru Yasujima, et al.. (1979). A CASE OF FAMILIAL IDIOPATHIC HYPERALDOSTERONISM. Nihon Naika Gakkai Zasshi. 68(9). 1119–1125. 1 indexed citations
5.
Yasujima, Minoru, Keishi Abe, Nobuo Irokawa, et al.. (1978). Urinary prostaglandin and sodium metabolism in patients with essential hypertension.. The Tohoku Journal of Experimental Medicine. 124(3). 277–283. 7 indexed citations
6.
Abe, K., Minoru Yasujima, Nobuo Irokawa, et al.. (1978). The Role of Intrarenal Vasoactive Substances in the Pathogenesis of Essential Hypertension. Clinical Science. 55(s4). 363s–366s. 16 indexed citations
7.
Yasujima, Minoru, Keishi Abe, Satoru Chiba, et al.. (1978). Implication of Renal Prostaglandin E in Urinary Sodium Excretion : VII CONFERENCE ON THE PATHOGENESIS OF HYPERTENSION. Japanese Circulation Journal. 42(5). 565–569. 5 indexed citations
8.
SEINO, MASAHIDE, Keishi Abe, Nobuo Irokawa, et al.. (1978). Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.. The Tohoku Journal of Experimental Medicine. 124(3). 197–203. 8 indexed citations
9.
Irokawa, Nobuo, Minoru Yasujima, MASAHIDE SEINO, et al.. (1978). The kallikrein-kinin system and prostaglandins in the kidney: their relation to forosemide-induced diuresis and to the renin-angiotensin-aldosterone system in man.. Circulation Research. 43(2). 254–260. 58 indexed citations
10.
Abe, Keishi, MASAHIDE SEINO, Satoru Chiba, et al.. (1977). Studies on renomedullary prostaglandin and renal kallikrein-kinin system in hypertension.. Japanese Circulation Journal. 41(8). 873–880. 16 indexed citations
11.
Yasujima, Minoru, Keishi Abe, Satoru Chiba, et al.. (1977). Effects of 1-Sar-8-Ile-Angiotensin II on Urinary Prostaglandin Excretion in Patients with Essential Hypertension. The Tohoku Journal of Experimental Medicine. 123(3). 271–278. 1 indexed citations
12.
Abe, Keishi, Minoru Yasujima, MASAHIDE SEINO, et al.. (1976). Metabolism of PG in man: Effect of furosemide on the excretion of the main metabolite of PG F2α. Prostaglandins. 12(5). 843–848. 10 indexed citations
13.
Abe, Keishi, et al.. (1976). Elevated Plasma Renin Activity in Aortitis Syndrome. Japanese Heart Journal. 17(1). 1–11. 13 indexed citations
14.
K, Abe, et al.. (1975). [Sodium metabolism in essential hypertension. Renin subgroups and changes of urinary sodium excretion caused by furosemide].. PubMed. 17(2). 63–8. 1 indexed citations
15.
Saito, Tetsuo, Keishi Abe, Seiji Miyazaki, et al.. (1975). PLASMA PROSTAGLANDIN E_1 LEVELS IN VARIOUS TYPES OF HYPERTENSION. Japanese Circulation Journal-english Edition. 39(9). 1056. 2 indexed citations
16.
Abe, Keishi, et al.. (1975). Renovascular hypertension. Blood & Vessel. 6(8). 627–637. 1 indexed citations
17.
Abe, Keishi, Tetsuo Saito, Seiji Miyazaki, et al.. (1975). Renal effects of prostaglandin E1 in hypertensive patients.. The Tohoku Journal of Experimental Medicine. 116(4). 351–358. 8 indexed citations
18.
Irokawa, Nobuo, et al.. (1973). [Plasma renin activity in essential hypertension].. PubMed. 15(11). 949–60. 1 indexed citations
19.
Abe, Keishi, Tetsuo Saito, Nobuo Irokawa, et al.. (1973). Seven Cases of Hypertension Due to Segmental Renal Ischemia. Japanese Heart Journal. 14(2). 110–125. 4 indexed citations
20.
Abe, Keishi, Tetsuo Saito, Seiji Miyazaki, et al.. (1972). Measurement of Plasma Renin Activity by Angiotensin I Radioimmunoassay: A Modification of Haber's Method. Japanese Circulation Journal. 36(7). 741–749. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T Haruyama Breakdown of academic impact, for papers by C Werning Breakdown of academic impact, for papers by P. Speckart Breakdown of academic impact, for papers by Jorge A. Lopez-Ovejero Breakdown of academic impact, for papers by Lawrence Levine Breakdown of academic impact, for papers by Jiří Heller Breakdown of academic impact, for papers by J. R. H. Brentjens Breakdown of academic impact, for papers by Markus Küng Breakdown of academic impact, for papers by Jan Malý Breakdown of academic impact, for papers by Ahmad A. Attallah
Rankless by CCL
2026